Physician
Nathanael David Gay, M.D.
According to 2025 Medicare claims, Nathanael Gay, M.D. (NPI: 1417214420) practices hematology/oncology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is CANCER CARE NORTHWEST CENTERS P S (NPI: 1922072081; TIN: 911007627) and primary practice location at 99202-1311. Gay is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.
Gay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 426 traditional Medicare patients, billed 1,028 HCPCS/CPT codes, and received $91,119 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,424 prescription claims across 349 beneficiaries totaling $8,141,657 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 69 claims. Open Payments data shows 3 records totaling $70. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,393 to $91,119. Similarly, Part D prescription costs have risen steadily, from $41,510 to $8,141,657. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.